Core Historical Cash Flow
| CLB Stock | USD 15.52 0.13 0.84% |
Analysis of Core Laboratories cash flow over time is an excellent tool to project Core Laboratories future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 4.2 M or Free Cash Flow of 41.2 M as it is a great indicator of Core Laboratories ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Core Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Laboratories is a good buy for the upcoming year.
Core |
About Core Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Core balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Core's non-liquid assets can be easily converted into cash.
Core Laboratories Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Core Laboratories to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Core Laboratories operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Core Laboratories' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Core Laboratories' Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 4.2 M, whereas Free Cash Flow is forecasted to decline to about 41.2 M.
Core Laboratories cash flow statement Correlations
Click cells to compare fundamentals
Core Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Core Laboratories cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 1.5M | (4.5M) | (14.9M) | (13.0M) | 9.4M | 9.8M | |
| Change In Cash | 2.7M | 3.9M | (2.3M) | (308K) | 4.0M | 4.2M | |
| Free Cash Flow | 46.0M | 23.0M | 14.7M | 14.2M | 43.4M | 41.2M | |
| Change In Working Capital | 35.1M | (11.5M) | (9.6M) | (28.8M) | 7.9M | 8.3M | |
| Begin Period Cash Flow | 11.1M | 13.8M | 17.7M | 15.4M | 15.1M | 29.5M | |
| Other Cashflows From Financing Activities | (1.8M) | 153.6M | 113.4M | (5.4M) | (775K) | (736.3K) | |
| Depreciation | 20.9M | 18.5M | 17.2M | 15.8M | 15.0M | 21.7M | |
| Other Non Cash Items | 103.7M | (15.8M) | (10.5M) | (2.4M) | (3.0M) | (2.9M) | |
| Dividends Paid | 12.4M | 1.8M | 1.9M | (1.9M) | (1.9M) | (1.8M) | |
| Capital Expenditures | 11.9M | 13.5M | 10.2M | 10.6M | 13.0M | 16.7M | |
| Total Cash From Operating Activities | 57.9M | 36.6M | 25.0M | 24.8M | 56.4M | 110.0M | |
| Net Income | (96.9M) | 20.2M | 19.7M | 37.0M | 32.2M | 30.5M | |
| Total Cash From Financing Activities | (63.0M) | (22.5M) | (23.4M) | (18.4M) | (46.0M) | (48.3M) | |
| End Period Cash Flow | 13.8M | 17.7M | 15.4M | 15.1M | 19.2M | 30.0M | |
| Stock Based Compensation | 7.4M | 19.1M | 7.8M | 14.0M | 3.8M | 3.6M | |
| Other Cashflows From Investing Activities | 19.7M | 2.4M | 6.4M | 3.9M | 6.6M | 7.0M | |
| Change To Liabilities | 1.3M | (29.6M) | 6.6M | 3.6M | 3.3M | 2.7M | |
| Change To Account Receivables | 46.4M | (13.5M) | (10.1M) | (2.6M) | (3.6M) | (3.4M) | |
| Sale Purchase Of Stock | (2.8M) | (8.3M) | (3.9M) | (2.2M) | (5.3M) | (5.6M) | |
| Total Cashflows From Investing Activities | (5.7M) | 7.9M | (10.2M) | (3.9M) | (4.4M) | (4.7M) | |
| Change Receivables | (3.2M) | 46.4M | (13.5M) | (10.1M) | (11.6M) | (11.0M) | |
| Net Borrowings | 15M | (47.5M) | (71M) | (17.2M) | (15.5M) | (14.7M) | |
| Cash And Cash Equivalents Changes | (2.0M) | 2.7M | 3.9M | (2.3M) | (2.6M) | (2.7M) | |
| Cash Flows Other Operating | (1.2M) | 122.1M | (316K) | (3.3M) | (3.8M) | (3.6M) | |
| Change To Netincome | (28.1M) | (5.8M) | 9.8M | 12.7M | 11.4M | 9.8M | |
| Investments | 7.9M | (10.2M) | (3.9M) | (6.7M) | (6.4M) | (6.7M) | |
| Change To Operating Activities | 8.6M | (21.2M) | (11.4M) | (13.6M) | (12.3M) | (11.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.896 | Dividend Share 0.04 | Earnings Share 0.66 | Revenue Per Share | Quarterly Revenue Growth 0.008 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.